-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Day One Biopharmaceutical, Maintains $36 Price Target

Benzinga·04/03/2025 10:43:21
Listen to the news
HC Wainwright & Co. analyst Andres Maldonado reiterates Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and maintains $36 price target.